Medisafe Maestro Accelerates Digital Health with Two Top Pharma Programs Released in Past 30 Days, And More Coming this Quarter

Boston, MA Nov. 18 – Medisafe, the premier platform for medication management and patient retention, is announcing several groundbreaking partnerships with major pharmaceutical brands in 2024, including two program launches with top US pharma brands in the past 30 days using Medisafe Maestro (see a demo).

Medisafe’s Maestro Platform enables pharma and life science partners to launch digital companions and software-enabled drug programs to their specifications

The releases underscore Medisafe’s unmatched ability to drive innovation and deliver measurable impact while solidifying Medisafe’s position as the go-to solution for pharma executives seeking to elevate adherence, retention, and patient outcomes at scale.

“We are excited by the momentum we’ve seen in recent months,” said Omri Shor, CEO of Medisafe. “These partnerships represent a pivotal shift in how pharma companies and patient support teams approach patient outcomes. Our Maestro ‘no-code’ platform is built to efficiently address the specific challenges patients and brands face, and we are proud to work with partners who share our vision of transforming patient care through digital.

In the past 30 days, two launches using Medisafe Maestro are reinventing how patients manage their treatments and empowering them to take control of their healthcare journeys, while simultaneously delivering measurable value to Medisafe’s pharmaceutical partners. Specifically Medisafe enables pharma and patients to:

• Transform Patient Care: Harness digital solutions to drive adherence, improve outcomes, and support patient success;
• Empower Patients: Equip patients and caregivers with tools to take control of their treatments and achieve better health outcomes;
• Boost Engagement Metrics: Unlock higher patient interaction and loyalty with measurable results;
• Stay Fully Compliant: Keep software solutions fully updated with ISO certifications, HIPAA, GDPR and SaMD and PDURS-ready solutions for software-engaged drug programs;
• Maximize Adherence Rates: Ensure patients stay on track with their prescribed therapies, measurements, appointments; and
• Access Data-Driven Insights: Leverage actionable analytics to refine strategies and deliver measurable ROI.

“Medisafe is a great example of how using an innovative digital solution can really help solve patient challenges,” said a representative from one of Medisafe’s pharma partners. “By leveraging Medisafe’s advanced platform, we are able to offer patients real-time support, personalized reminders, and access to critical resources that empower them to take control of their treatment. This level of engagement not only improves patient outcomes but also strengthens our ability to drive adherence and successful engagements.”

These new partnerships reflect the growing recognition of the importance of personalized, data-driven patient support programs. While Medisafe does not disclose partner names to maintain the privacy of both patients and pharmaceutical brands, the impact of these collaborations is significant value generation, setting a new standard for patient engagement across the industry.

“The program implementation was a dedicated effort with a lot of passion,” said another pharma launch partner. “Medisafe is spot on for what we need to improve patient lives.”

For more information on Medisafe’s groundbreaking digital health platform and partnership opportunities, get a demo of Maestro or contact [email protected]

About Medisafe
Medisafe is the leading medication engagement company that empowers patients to seamlessly manage their treatment journey and holistic health to drive outcomes, while providing real-time intelligence from a database of 50B+ data points. By combining advanced technology with behavioral science, Medisafe’s multiple options support patients, providers, and payers at-scale by supporting better engagement, health management, and outcomes. Over 13M registered patients and caregivers rely on Medisafe’s HIPAA and GDPR compliant solution, which is also ISO 27001:2013 and ISO 13845 certified.